Impact of community-associated, methicillin-resistant Staphylococcus aureus on management of the skin and soft tissue infections in children

This publication has 58 references indexed in Scilit:

• Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus
  The Pediatric Infectious Disease Journal, 2005
• Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles
  New England Journal of Medicine, 2005
• Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak
  Journal of the American Academy of Dermatology, 2004
• Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus
  The Pediatric Infectious Disease Journal, 2004
• Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children
  The Pediatric Infectious Disease Journal, 2003
• Safety and tolerability of linezolid
  Journal of Antimicrobial Chemotherapy, 2003
• Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children
  The Pediatric Infectious Disease Journal, 2002
• Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
  The Lancet, 2002
• Exotoxins of Staphylococcus aureus
  Clinical Microbiology Reviews, 2000
• Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
  Journal of Antimicrobial Chemotherapy, 1999